June 20, 2019
Already approved FDA drug could impact brain cell function IMAGE: Baboons at the Southwest National Primate Research Center. Credit: Kathy West Studios Texas Biomedical Research Institute San Antonio, Texas (June 17, 2019) – The William and Ella Owens Medical Research Foundation has awarded Texas Biomed Associate Professor Marcel Daadi, Ph.D., with a grant of more […]
Read more
June 6, 2019
ISSCR News – 5 June, 2019 – The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, opposes the new U.S. Health and Human Services policy to eliminate federal funding for fetal tissue research in the National Institutes of Health (NIH) intramural research program. This […]
Read more
June 4, 2019
FDA Press Release: June 04, 2019 – U.S. District Judge Ursula Ungaro of the Southern District of Florida granted the government’s motion for summary judgment against US Stem Cell Clinic LLC, of Weston, Florida, and US Stem Cell Inc., of Sunrise, Florida, and their Chief Scientific Officer Kristin Comella, Ph.D. The court held that the […]
Read more
May 31, 2019
DURHAM, N.C. (PRWEB)May 30, 2019 – A study released today in STEM CELLS Translational Medicine is the first to demonstrate an efficient delivery system for the sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) to treat acute kidney injuries. The platelet-rich plasma-based gel system was able to deliver CM into the injured […]
Read more
May 11, 2019
WINSTON-SALEM, NC – The sixth annual Regenerative Medicine Essentials Course will be held June 10 – 14 in downtown Winston-Salem. The course is made possible through the collaborative partnership between the Regenerative Medicine Foundation (RMF) and the Wake Forest Institute for Regenerative Medicine (WFIRM). The Regenerative Medicine Essentials Course – the “official course” of the […]
Read more
May 9, 2019
One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025, according to Bank of America analysts. The analysts say companies such as Illumina and Alphabet are on the cusp of “bringing unprecedented increases to […]
Read more
May 8, 2019
Under a draft proposal, patients would be able to buy some therapies without regulatory approval. By: David Cyranoski Select elite hospitals in China could soon be able to sell experimental therapies that engineer a patient’s own cells to treat diseases such as cancer — without approval from the nation’s drug regulator. The proposal comes three […]
Read more
April 30, 2019
Dr. Anthony Atala in the Regenerative medicine laboratories, Wake Forest Institute for Regenerative Medicine (WFIRM). by Vanesa Listek | 17 hours ago | 3D Printing, Bioprinting, Exclusive Interviews, Featured Stories, Medical 3D Printing | Anthony Atala is a pediatric surgeon, urologist and directs the Wake Forest Institute for Regenerative Medicine (WFIRM) in North Carolina. […]
Read more
April 25, 2019
KENNEDY SPACE CENTER (FL), April 22, 2019 – The International Space Station (ISS) U.S. National Laboratory is finalizing more than a dozen payloads for launch to the orbiting laboratory aboard SpaceX’s Dragon spacecraft. Many of these payloads are aimed at improving human health on Earth, with several focused on drug development and screening. Research concepts […]
Read more
